29.06.2010
Rob Koremans appointed new Chief Executive Officer of Zentiva
Zentiva’s Chief Executive Officer Jiri Michal to Step Down
Prague, Czech Republic - June 29, 2010 - Sanofi-aventis announced ...
|
28.05.2010
Further Details regarding Reimbursement Procedure for Former Minority Shareholders of Zentiva N.V.
Prague, May 28, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY)
Further Details regarding Reimbursement Procedure for ...
|
22.03.2010
Payment and consignment of squeeze out price. Sanofi-Aventis Europe is now 100% shareholder of Zentiva NV
Prague, March 22, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY)
On 23 February 2010, the Amsterdam Court of Appeal ...
|
04.03.2010
Updated information on Zentiva N.V.'s squeeze-out
Prague, March 04, 2010 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY)
Following the public offer completed on March 11, ...
|
08.09.2009
Rob Koremans appointed Senior Vice President, Generics Europe and President of Zentiva
September 2, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) is pleased to announce today that Rob Koremans ...
|
28.04.2009
Delisting of Zentiva’s shares from the Prague Stock Exchange
Prague, April 28, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces that the termination of the listing of its ordinary ...
|
24.04.2009
Zentiva N.V. – Cancellation of the Listing of Global Depositary Shares Becomes Effective
Prague, London, April 24, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces that the termination of the listing of its outstanding global ...
|
02.04.2009
Zentiva N.V. - Results of Extraordinary General Meeting held on April 2, 2009
Prague, London, April 2, 2009 - Zentiva N.V. (“Zentiva” or the “Company”) is pleased to announce that it held its Extraordinary ...
|
24.03.2009
Zentiva N.V. – Notice of Intention to Cancel the Listing of Global Depositary Shares
Prague, London, March 24, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces, in accordance with the requirement ...
|
24.03.2009
Zentiva to apply for termination of its listing on the Prague Stock Exchange
Prague, London, March 24, 2009 – Today, Zentiva N.V. (the “Company” or “Zentiva”) applied to the Prague Stock Exchange for termination ...
|
23.03.2009
Zentiva produces strong 2008 operating results
Larger, better balanced business delivers expected sales
and efficiency benefits
EBIT increased ...
|
12.03.2009
Sanofi-Aventis becomes majority shareholder of Zentiva
Prague, London, March 12, 2009 – Today, Sanofi-Aventis Europe announced that it has became an approximately 96.8% shareholder of Zentiva ...
|
11.03.2009
Zentiva issues new shares
Zentiva Board decides to initiate delisting from the Prague Stock Exchange
Prague, London, March 11, 2009 – Today, ...
|
25.02.2009
Sanofi-Aventis announces successful takeover of Zentiva
Prague, London, February 25, 2009 – Sanofi-Aventis announced today that all of the conditions to its recommended voluntary CZK ...
|
13.02.2009
Zentiva to issue new shares to cover exercised employee stock options
Prague, London, February 13, 2009 – Zentiva N.V. ("Zentiva" or the “Company") announces that its Board has decided on the conditional ...
|
10.02.2009
PPF withdraws its court action against Zentiva
Prague, London, February 10, 2009 – Zentiva N.V. ("Zentiva" or the “Company") notes the announcement by Anthiarose Limited, a wholly ...
|
09.02.2009
Zentiva N.V. - Results of Extraordinary General Meeting held on February 9, 2009
Prague, London, February 9, 2009– Zentiva N.V. (“Zentiva” or the “Company”) is pleased to announce that it held its Extraordinary ...
|
04.02.2009
The European Commission clears acquisition of Zentiva by Sanofi-Aventis
The Board of Directors of Zentiva continues to recommend the improved Sanofi-Aventis takeover offer of CZK 1,150 in cash per share
Zentiva ...
|
04.02.2009
PPF notifies Zentiva of court action to attempt to call EGM to replace Zentiva's Board
ZENTIVA BELIEVES PPF’S SUIT IS WITHOUT MERIT
Prague, London, February 4, 2009 – Zentiva N.V. ("Zentiva" or ...
|
10.11.2008
Zentiva produces strong first nine month results
Successful Integration of the Turkish Business and Focus on Efficiency Lead to 61.7% increase in EBIT to CZK 2,361.2 million1
Prague, ...
|
|
1
2
3
4
5
|
| |